Positron Emission Tomography (PET) Imaging Facility
The Positron Emission Tomography (PET) Facility at Houston Methodist offers a wide variety of highly customizable advanced imaging services including the production of cGMP grade radiopharmaceuticals and research-dedicated PET scanning of patients and large preclinical models using a state-of-the-art research-dedicated Siemens Vision and Quadra PET/CT scanners. The PET facility is fully equipped to perform kinetic modelling studies with arterial input function and correction for radiometabolites.
The production of radiopharmaceuticals is performed by the Cyclotron and Radiopharmaceutical Core in compliance with FDA regulatory requirements. We support research studies involving novel tracers for imaging of brain and other tumors, and neurodegenerative diseases. Additional novel radiopharmaceuticals which are in the pipeline are used for imaging molecular processes involving inflammation and for specific protein detection such as amyloid or tau. For more on the tracer production component of our core, visit the Cyclotron and Radiopharmaceutical Core.
The production of radiopharmaceuticals is performed by the Cyclotron and Radiopharmaceutical Core in compliance with FDA regulatory requirements. We support research studies involving novel tracers for imaging of brain and other tumors, and neurodegenerative diseases. Additional novel radiopharmaceuticals which are in the pipeline are used for imaging molecular processes involving inflammation and for specific protein detection such as amyloid or tau. For more on the tracer production component of our core, visit the Cyclotron and Radiopharmaceutical Core.
Core Director:
Moonsoo Jin, PhD
mjin@houstonmethodist.org
713.441.0803